Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations

Fam Cancer. 2018 Jul;17(3):317-319. doi: 10.1007/s10689-017-0020-z.

Authors

Jacopo Azzollini¹, Milena Mariani², Bernard Peissel², Siranoush Manoukian²

Affiliations

¹ Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. jacopo.azzollini@istitutotumori.mi.it.
² Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms*
Breast*
Humans
Tumor Suppressor Protein p53

Substances

TP53 protein, human
Tumor Suppressor Protein p53